Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Other Non-Current Liabilities (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed Other Non-Current Liabilities for 2 consecutive years, with $73000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Other Non-Current Liabilities changed 0.0% to $73000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $73000.0, a 0.0% change, with the full-year FY2024 number at $73000.0, changed 0.0% from a year prior.
  • Other Non-Current Liabilities was $73000.0 for Q4 2024 at Artiva Biotherapeutics, roughly flat from $73000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $73000.0 in Q4 2023 to a low of $73000.0 in Q4 2023.